Crucial role of HO-1/IRF4-dependent apoptosis induced by panobinostat and lenalidomide in multiple myeloma-Reference-Cited by-同舟云学术

Crucial role of HO-1/IRF4-dependent apoptosis induced by panobinostat and lenalidomide in multiple myeloma

Published:2018-02 Issue:2 Volume:363 Page:196-207
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Tang Sishi,Ma Dan,Cheng Bingqing,Fang Qing,Kuang Xingyi,Yu Kunling,Wang Weili,Hu Bo,Wang Jishi

Funder

National Natural Science Foundation of China

International Cooperation Project of Guizhou Province

Social Project of Guizhou Province

Key Discipline of Guizhou Province, Provincial Governor Special Fund of Guizhou Province

Regional Science Foundation of Guizhou Province

Publisher

Elsevier BV

Subject

Cell Biology

Reference35 articles.

1. Multiple myeloma: biology of the disease;Mahindra;Blood Rev.,2010

2. Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma;Conery;Elife,2016

3. Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay;Abruzzese;J. Hematol. Oncol.,2016

4. IRF4 addiction in multiple myeloma;Shaffer;Nature,2008

5. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma;Keats;Cancer Cell,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect;International Journal of Hematology;2024-07-02

2. Targeting the ribosome to treat multiple myeloma;Molecular Therapy: Oncology;2024-03

3. The selective activator protein-1 inhibitor T-5224 regulates the IRF4/MYC axis and exerts cooperative antimyeloma activity with bortezomib;Chemico-Biological Interactions;2023-10

4. Histone deacetylase‐based dual targeted inhibition in multiple myeloma;Medicinal Research Reviews;2023-05-16

5. Regulatory network of BLIMP1, IRF4, and XBP1 triad in plasmacytic differentiation and multiple myeloma pathogenesis;Cellular Immunology;2022-10